ARCHIVES

A Year in Houston: DePinho Reflects on Plans, Conflicts, Controversies—and Lessons Learned

This article is from The Cancer Letter archive.

Vol. 38 No. 33 | September 7, 2012

Download PDF Visit The Full Archive

Related Articles

NIH Limits Salaries On Grants, Contracts ACS Clinical Awards Available For 1995

February 25, 1994

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

NIH Eyes FCRC For Intramural Space As Contract Recompetition Planning Nears

May 23, 1980

AIDS Commission Asks, “Give Us A Chance”

September 18, 1987

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

July 31, 2009

NCI’s Independence To Be Challenged By Edwards When Cancer Act Comes Up For Renewal Next Year

December 21, 1973